Clinical Trial Sites

The following are locations participating in the clinical trial to evaluate PCS499 in treating ulcerations in patients who have Necrobiosis Lipoidica:

Necrobiosis Lipoidica Study Clinical Trial Sites

Processa Pharmaceuticals will cover travel costs (air, train, hotel, etc) for patient’s needing to travel to clinical sites. Please contact a Clinical Investigator to find out if you can participate in the clinical study.

San Diego, California, 92123

Contact: Carlos Vega
858-278-8470 ext 3
carlos@univct.com
Principal Investigator:
Walter Nahm, MD

Rochester, Minnesota, 55905

Contact: Gabrielle Klemme
507-266-7838
klemme.gabrielle@mayo.edu
Principal Investigator:
Afsaneh Alavi, MD

Philadelphia, Pennsylvania, 19104

Contact: Alaina Hunt
267-664-0531
alaina.hunt@pennmedicine.upenn.edu
Principal Investigator:
Misha Rosenbach, MD

Charleston, South Carolina, 29407

Contact: Samara Grimes
843-556-8886
samara.grimes@dermandlaser.com
Contact: Jenna Goodman
843-556-8886
jenna.goodwin@dermlaser.com
Principal Investigator: Todd Schlesinger, MD

Milwaukee, Wisconsin, 53266

Contact: Daniel Benitez-Rivera
414-955-2846
dbenitez@mcw.edu
Principal Investigator:
Karolyn Wanat, MD